Controlled Clinical Trials

Published by: Elsevier Science, Inc.  

People

  1. Gonen
    Gonen
  2. Begg
    Begg
  3. Chapman
    Chapman
  4. Heller
    Heller
  5. Panageas
    Panageas
  6. Scher
    Scher
  7. Vickers
    Vickers

Groups

  1. Epidemiology and Biostatistics (5)
  2. Biostatistics Service (4)
  3. Population Sciences Research Program (3)
  4. Hepatopancreaticobiliary Disease Management Team (2)
  5. Solid Tumor Oncology Division (2)
  6. Central Nervous System Disease Management Team (1)
  7. Genitourinary Disease Management Team (1)
  8. Genitourinary Oncology Service (1)
  9. Health Outcomes Research Group (1)
  10. Integrative Medicine Disease Management Team (1)
Search Within
Refine Results
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Epidemiology and Biostatistics (5)
  2. Biostatistics Service (4)
  3. Population Sciences Research Program (3)
  4. Hepatopancreaticobiliary Disease Management Team (2)
  5. Solid Tumor Oncology Division (2)
  6. Central Nervous System Disease Management Team (1)

More Groups

People
  1. Madhu Mazumdar (2)
  2. Mithat Gonen (2)
  3. Alexander Smith (1)
  4. Andrew Vickers (1)
  5. Colin Begg (1)
  6. Denis Leung (1)

More People

Years
  1. 2003 (4)
  2. 2002 (1)
  3. 2001 (1)
  4. 2000 (2)
Publishers
  1. Elsevier Science, Inc. (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficiency of strta matched case-control studies with multiple controls per case in survival data setting
    Meeting Abstract

    Mazumdar, M.; Tu, D.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • Comparison of methods for estimating area under the toxicity curve in the QTWiST setting
    Meeting Abstract

    Bacik, J.; Mazumdar, M.; Zbrozek, A.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • Use of a single global assessment to reduce missing data in a clinical trial with follow-up at one year
    Journal Article

    Vickers, A. J.; McCarney, R.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • Planning for subgroup analysis: A case study of treatment-marker interaction in metastatic colorectal cancer
    Journal Article

    Gonen, M.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • An optimal two-stage phase II design utilizing complete and partial response information separately
    Journal Article

    Panageas, K. S.; Smith, A.; Gonen, M.; Chapman, P. B.
    Controlled Clinical Trials (2002)

    Fulltext@MSK | Save
  • Isotonic designs for phase I trials
    Journal Article

    Leung, D. H. Y.; Wang, Y. G.
    Controlled Clinical Trials (2001)

    Fulltext@MSK | Save
  • Ruminations on the intent-to-treat principle
    Journal Article

    Begg, C. B.
    Controlled Clinical Trials (2000)

    Fulltext@MSK | Save
  • The phase II/III transition: Toward the proof of efficacy in cancer clinical trials
    Journal Article

    Fazzari, M.; Heller, G.; Scher, H. I.
    Controlled Clinical Trials (2000)

    Fulltext@MSK | Save

    • Controlled Clinical Trials – authorized name for:

    Name ISSN / ISBN Publisher
    Controlled Clinical Trials 01972456 Unknown
    Controlled Clinical Trials 0197-2456 Unknown
    Controlled Clinical Trials 0197-2456 Elsevier Science, Inc.
    Controlled Clinical Trials 0197-2456 Elsevier Inc.
    Controlled Clinical Trials 0197-2456 Elsevier Science, Inc.
    Controlled Clinical Trials 0197-2456 Elsevier Inc.
    Controlled Clinical Trials 0197-2456 Elsevier Science, Inc.